Drug Safety Associate at SMB
High Conscientiousness and Emotional Stability to process ICSRs, meet expedited reporting deadlines, and maintain the pharmacovigilance database.
In SMB pharma, quality and compliance are the license to operate
The development pipeline is the company's valuation and main asset
The relationship with local health authorities is capital built over years
Ideal OCEAN+ Profile
At SMBs (51-200 employees), ability to interpret complex cases, identify emerging signals, and adapt processes to new ICH E2 guidelines and local regulations
At SMBs (51-200 employees), precision in documenting adverse events, meeting expedited deadlines (7/15 days), and maintaining the pharmacovigilance database
At SMBs (51-200 employees), communication with physicians and reporters to obtain additional case information; internal presentations of safety metrics
At SMBs (51-200 employees), collaboration with medical, regulatory, and legal teams to evaluate and manage complex safety cases
At SMBs (51-200 employees), tolerance for peak case volumes, pressure from regulatory deadlines, and the distressing nature of serious adverse event report content
At SMBs (51-200 employees), the pharmacovigilance associate operates under regulatory reporting deadlines for adverse events (15 days for SUSARs, 7 days for fatal cases) and defined case-handling processes; adherence to case processing pace is non-negotiable
Strengths and Red Flags
Strengths
- Accurate, on-time processing of ICSRs within expedited regulatory deadlines
- Maintaining the quality and consistency of the safety database
- Managing development pipelines balancing innovation with commercial viability
- GMP and regulatory compliance with limited internal quality teams
Red Flags
- Case processing errors that cause expedited reports to miss deadlines
- Inconsistent MedDRA term coding that compromises signal detection
- Difficulty maintaining compliance with limited quality resources
- Resists outsourcing activities it can't perform internally
Interview Questions
How many cases do you process on average per month? What is your expedited deadline compliance rate, and how do you handle volume spikes?
Evaluates: Conscientiousness and management of high-precision operational workload
Describe your process for coding MedDRA terms on a case with multiple adverse events. What criteria do you use to select the most appropriate term?
Evaluates: Conscientiousness and technical rigor in safety processing
How did you maintain GMP compliance with limited quality teams?
Evaluates: Conscientiousness and efficiency in quality management
How did you balance innovation with commercial viability in your pipeline?
Evaluates: Balance between scientific rigor and business pragmatism
More about Drug Safety Associate
Career path, personality archetypes and similar roles in the full profile.
This Role in Other Contexts
Drug Safety Associate — base profile with no company context
View profile → Startup (1-50 employees)In pharma startups, time to regulatory approval defines survival
View profile → Enterprise (201-1000 employees)In enterprise pharma, multi-market regulatory complexity is the norm
View profile → Global (1001+ employees)Global pharma means registrations in dozens of markets with different requirements
View profile →Does your next Drug Safety Associate at SMB (51-200 employees) match this profile?
Map anyone's OCEAN+ profile with the Talent Diagnostic: free, no signup, 10 minutes.
20 statements · 10 minutes · no card